Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Text Messaging | 1 | 2020 | 389 | 0.58 | Why? |
| Pneumococcal Vaccines | 2 | 2019 | 571 | 0.25 | Why? |
| Pneumococcal Infections | 2 | 2019 | 562 | 0.24 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.21 | Why? |
| Republic of Korea | 10 | 2021 | 5858 | 0.20 | Why? |
| Scrub Typhus | 1 | 2019 | 68 | 0.18 | Why? |
| Diabetes Complications | 2 | 2020 | 2358 | 0.17 | Why? |
| Bunyaviridae Infections | 1 | 2019 | 107 | 0.17 | Why? |
| Culture Media, Conditioned | 1 | 2017 | 66 | 0.17 | Why? |
| Phlebotomus Fever | 1 | 2016 | 44 | 0.16 | Why? |
| Vaccines, Conjugate | 1 | 2019 | 328 | 0.16 | Why? |
| Tick-Borne Diseases | 1 | 2016 | 68 | 0.15 | Why? |
| Pneumonia, Pneumococcal | 1 | 2019 | 251 | 0.15 | Why? |
| Bronchiectasis | 1 | 2020 | 312 | 0.15 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.15 | Why? |
| Arthritis, Rheumatoid | 2 | 2018 | 2043 | 0.13 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.13 | Why? |
| Regeneration | 1 | 2017 | 429 | 0.13 | Why? |
| Fever | 3 | 2020 | 7795 | 0.13 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.12 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.12 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.11 | Why? |
| Stem Cells | 1 | 2017 | 595 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Medication Adherence | 2 | 2018 | 1270 | 0.11 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.11 | Why? |
| Thrombocytopenia | 3 | 2020 | 2093 | 0.10 | Why? |
| Plasma Exchange | 1 | 2017 | 763 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.09 | Why? |
| Antirheumatic Agents | 2 | 2020 | 3023 | 0.08 | Why? |
| Phlebovirus | 2 | 2019 | 106 | 0.08 | Why? |
| Serogroup | 2 | 2019 | 510 | 0.08 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| Skin | 1 | 2017 | 2096 | 0.07 | Why? |
| Rheumatic Diseases | 1 | 2020 | 2675 | 0.07 | Why? |
| Streptococcus pneumoniae | 2 | 2019 | 827 | 0.06 | Why? |
| Multivariate Analysis | 3 | 2020 | 5440 | 0.06 | Why? |
| Bronchography | 1 | 2020 | 13 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
| Bronchioles | 1 | 2020 | 33 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Logistic Models | 3 | 2021 | 9089 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Lymphocytosis | 1 | 2020 | 122 | 0.05 | Why? |
| Orientia tsutsugamushi | 1 | 2019 | 45 | 0.05 | Why? |
| C-Reactive Protein | 3 | 2021 | 7972 | 0.05 | Why? |
| Factor Analysis, Statistical | 1 | 2020 | 538 | 0.04 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.04 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.04 | Why? |
| Collagen Type I | 1 | 2017 | 56 | 0.04 | Why? |
| Aged | 11 | 2021 | 215776 | 0.04 | Why? |
| Leukopenia | 1 | 2019 | 280 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Ticks | 1 | 2016 | 107 | 0.04 | Why? |
| Immunization Programs | 2 | 2019 | 2006 | 0.04 | Why? |
| Humans | 19 | 2021 | 930598 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.04 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.04 | Why? |
| Male | 13 | 2021 | 367725 | 0.04 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Physical and Rehabilitation Medicine | 1 | 2020 | 469 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2020 | 1329 | 0.03 | Why? |
| Female | 12 | 2021 | 380317 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Wound Healing | 1 | 2017 | 424 | 0.03 | Why? |
| Ageism | 1 | 2018 | 361 | 0.03 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.03 | Why? |
| Geriatrics | 1 | 2020 | 947 | 0.03 | Why? |
| Blood Pressure | 1 | 2021 | 2198 | 0.03 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Psychiatry | 1 | 2020 | 1289 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Seasons | 1 | 2016 | 4071 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Vaccination | 2 | 2019 | 19050 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.01 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Exercise | 1 | 2020 | 6771 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Animals | 2 | 2017 | 78931 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Incidence | 1 | 2016 | 25622 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Hur's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(102)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_